Arbor Biotechnologies is a next-generation gene editing company committed to discovering and developing potentially curative genomic medicines. Utilizing a diverse range of proprietary genomic editors, Arbor approaches disease pathology with a tailored strategy, selecting the most effective editing tools for specific conditions. The company values purposeful action, bold resilience, and humble authenticity, fostering a collaborative and inclusive work environment. Team members are encouraged to embody qualities such as curiosity, resourcefulness, and accountability. Arbor is dedicated to driving innovation in the biotech field while maintaining a focus on ethical practices and the enhancement of patient care. With an emphasis on diverse perspectives and teamwork, Arbor Biotechnologies aims to create impactful solutions in the realm of genetic medicine.